Exhibit 99.4 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ ] Name and Address: Oracle Institutional Partners, L.P. c/o Oracle Associates, LLC 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 12/31/2005 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 12/31/2005 Transaction Code: P Securities Disposed: 82,745 Acquired or Disposed: A Price: $0.65 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/5/2006 Transaction Code: (J) (4) Securities Disposed: 222,116 Acquired or Disposed: D Price: $0.00 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/26/2007 Transaction Code: S Securities Disposed: 5,000 Acquired or Disposed: D Price: $7.314 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/27/2007 Transaction Code: S Securities Disposed: 100 Acquired or Disposed: D Price: $7.00 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/19/2007 Transaction Code: P Securities Disposed: 40,000 Acquired or Disposed: A Price: $5.17 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/12/2008 Transaction Code: P Securities Disposed: 29,736 Acquired or Disposed: A Price: $3.15 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/07 Transaction Code: J Securities Acquired: 76 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 253,600 Price of Derivative Securities: (7) Number Beneficially Owned 76 Ownership Form: D Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 11/10/07 Transaction Code: P Securities Acquired: 126,800 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 126,800 Price of Derivative Securities: (7) Number Beneficially Owned 126,800 Ownership Form: D Nature of Indirect Beneficial Ownership Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 3/11/08 (7) Transaction Code: P Securities Acquired: 72 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 240,000 Price of Derivative Securities: (8) Number Beneficially Owned 148 Ownership Form: D Nature of Indirect Beneficial Ownership Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 3/11/08 (7) Transaction Code: P Securities Acquired: 119,811 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 119,811 Price of Derivative Securities: (8) Number Beneficially Owned 246,611 Ownership Form: D Nature of Indirect Beneficial Ownership Explanation of Responses: (4), (6) - (9), (12), and (15) See Exhibit 99.1. Signature: ORACLE INSTITUTIONAL PARTNERS, L.P. By: Oracle Associates, LLC, its General Partner By: /s/ Larry N. Feinberg --------------------------------- Name: Larry N. Feinberg Title: Managing Member Date: June 10, 2008